Status:
COMPLETED
Gradual Vs. Rapid Buprenorphine Detoxification - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Vermont
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
33-43 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
June 1 1991
Trial Type :
INTERVENTIONAL
End Date :
July 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000220
Start Date
June 1 1991
End Date
July 1 2001
Last Update
June 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Treatment Research Center
Burlington, Vermont, United States, 05401